Cited by 15Reproductive Health and TechnologiesReproductive Biology and FertilityAssisted Reproductive Technology and Twin Pregnancy

Does GnRH agonist triggering control painful symptom scores during assisted reproductive technology? a retrospective study

Bourdon, Mathilde, Santulli, Pietro, de Ziegler, Dominique, Gayet, Vanessa, Maignien, Chloé, Marcellin, Louis, Chapron, Charles·2017·Reproductive Sciences

Abstract

Objective The aim of this study was to assess the progression of pain symptoms during assisted reproductive technology (ART) cycles following administration of GnRH agonist (GnRHa) versus human chorionic gonadotrophin (hCG) triggering.Design Observational cohort study.Setting A tertiary care university hospital in France.Population Patients who underwent ART programs.Methods Between January 01, 2014, and June 31, 2014, 122 cycles were allocated to 2 groups: GnRHa triggering with a scheduled differed embryo transfer (n = 57) or hCG triggering with a fresh embryo transfer (n = 70). Pelvic pain scores were evaluated using a visual analog scale (VAS) with regard to dysmenorrhea, dyspareunia, noncyclic pelvic pain, gastrointestinal, and lower urinary tract pain. The total VAS score was defined as the sum of the scores for the various symptoms. Evaluations were carried out twice: during the synchronization treatment prior to ovarian stimulation and during a final evaluation 3 weeks postretrieval. The data were processed using univariate and multivariate logistic regression models.Main outcome measures Trends for total VAS change (ie, final VAS score - synchronization VAS score).Results For both groups, pain increased during the ART procedure. Trends for the total VAS change revealed that the increase in pain was significantly less in the "GnRHa triggering" group compared to the "hCG triggering" group (3.77 ± 7.73 and 6.50 ± 6.57, P < .05, respectively). Multivariate logistic regression indicated that GnRHa triggering was associated with less of an increase in pain compared to hCG triggering (odds ratio = 0.31, 95% confidence interval 0.13-0.71, P < .05).Conclusion Compared to hCG, GnRHa triggering limits pain symptom progression in the period immediately after ART.

Integrity signals

Registry

Crossref · 10.1177/1933719116687659

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In endometriosis, ovarian stimulation with an antagonist protocol and ovulation triggering with a GnRH agonist did not increase endometriosis-related symptoms.

    “In endometriosis, we have reported that ovarian stimulation for ART using an antagonist protocol and triggering of the final step of ovulation with a GnRH-a did not increase endometriosis-related symptoms (56,57).”

    From Endometrial receptivity in adenomyosis and/or endometriosis (2023) · cites this paper as [56]

  • Embryo transfers conducted in estradiol and progesterone cycles may have a beneficial effect on endometrial receptivity.

    “Indeed, embryo transfers conducted in E 2 and progesterone cycles may have a beneficial effect on endometrial receptivity.”

    From Endometrial receptivity in adenomyosis and/or endometriosis (2023) · cites this paper as [56]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bourdon, M., Santulli, P., de Ziegler, D., Gayet, V., Maignien, C., Marcellin, L., & Chapron, C.
Affiliations
  • Sorbonne Paris Cité (FR)
  • Inserm (FR)
Venue
Reproductive Sciences
Published
2017-09
Volume
24
Issue
9
Pages
1325-1333
ISSN
  • 1933-7191 (ISSN-L)
  • 1933-7205
OpenAlex
W2571196529
Cited by
15
References
49
Citations by year
2025: 1 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1
FWCI
1.59
Type
journal article
Language
en
Open access
closed
Locations
  • Reproductive Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
Keywords
GnRH agonist triggering, assisted reproduction, pain symptoms, dysmenorrhea, dyspareunia, gastrointestinal pain, fresh embryo transfer, ovulation induction
MeSH terms
Adult, Female, Chorionic Gonadotropin, Humans, Menotropins, Ovulation Induction, Pregnancy, Retrospective Studies, Pelvic Pain, Reproductive Techniques, Assisted

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review